Picture of Amgen logo

AMGN Amgen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: OpenAI launches AI model GPT-Rosalind for life sciences research

April 16 (Reuters) - OpenAI:

OPENAI: GPT-ROSALIND NOW AVAILABLE AS RESEARCH PREVIEW IN CHATGPT, CODEX & API FOR QUALIFI ED CUSTOMERS THROUGH TRUSTED ACCESS PROGRAM

OPENAI: WORKING WITH CUSTOMERS LIKE AMGEN, MODERNA, THE ALLEN INSTITUTE, THERMO FISHER SCIENTIFIC & OTHERS TO APPLY GPT-ROSALIND ACROSS WORKFLOWS

OPENAI: INTRODUCING GPT-ROSALIND FOR LIFE SCIENCES RESEARCH

OPENAI: GPT-ROSALIND LAUNCHING THROUGH TRUSTED ACCESS DEPLOYMENT STRUCTURE FOR QUALIFIED ENTERPRISE CUSTOMERS IN U.S. TO START

OPENAI: SCIENTISTS CAN USE NEW LIFE SCIENCES RESEARCH PLUGIN FOR CODEX, AVAILABLE TODAY IN GITHUB

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Amgen

See all news